Richard Dinovitz is the Chief Commercial Officer and Executive Vice President. He has over 40 years of successful experience in the biotech, biological, vaccine, and pharmaceutical industries on both branded and generic platforms. As CCO he is responsible for the Tri-Source Pharma global strategy and the development of the organization to drive business growth and market share.

Richard is an accomplished officer-level executive with wide-ranging experience in complex technical markets. He is a creative thinker equally comfortable in strategic planning, business development, product launches, commercial team management, sales and marketing. He has spent over 30 years in positions of increasing responsibility with Pfizer where he consistently delivered strong financial growth through building high-performing teams, identifying/capitalizing on business and product specification opportunities, expanding distribution channels/networks, launching new products, and developing innovative marketing strategies. Additionally, he gained considerable expertise in government negotiation, commercial operations, strategic alliance management, and contracting. A proven leader that has consistently grown revenues, successfully bought and sold businesses, strengthened capital structures and strategically built management teams for greater effectiveness. He is a serial entrepreneur experienced in company startups, venture funding, co-promotions, mergers and acquisitions. Richard is a focused business executive who understands the need to consistently exceed expectations as well as to over-achieve aggressive targets with a sense of urgency on a routine basis.

Richard received his B.S. degree from the University of Pittsburgh and remains active in various Trade Organizations and Philanthropic Efforts.